(RDY) Dr. Reddy’s - Performance 2.6% in 12m
RDY performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
27.80%
#38 in Peer-Group
Rel. Strength
39.87%
#4615 in Stock-Universe
Total Return 12m
2.61%
#77 in Peer-Group
Total Return 5y
68.52%
#25 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 19.4 |
| P/E Forward | 19.0 |
| High / Low | USD |
|---|---|
| 52 Week High | 16.84 USD |
| 52 Week Low | 12.36 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 41.51 |
| Buy/Sell Signal +-5 | 0.13 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RDY (2.6%) vs XLV (-4.6%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
3.27% | 140% | 332% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
4.24% | 16.8% | 78.4% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
1.94% | -14.1% | 396% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NOVN SW Novartis |
0.79% | 3.78% | 49.4% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-6.42% | 2.63% | 46.3% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-4.86% | -7.48% | 108% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-4.86% | -8.38% | 44% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
-2.2% | -6.85% | 38.7% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: RDY vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for RDY
| Total Return (including Dividends) | RDY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 2.24% | 2.14% | 5.25% |
| 3 Months | 22.01% | 0.64% | 24.13% |
| 12 Months | 2.61% | -4.57% | 14.15% |
| 5 Years | 68.52% | 42.89% | 111.83% |
| Trend Score (consistency of price movement) | RDY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -53.2% | 35.8% | 81% |
| 3 Months | 91% | -28.5% | 96.9% |
| 12 Months | -58.5% | -74.5% | 44.9% |
| 5 Years | 61.7% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th58.50 | 0.09% | -2.86% |
| 3 Month | %th63.50 | 21.23% | -1.71% |
| 12 Month | %th62.00 | 7.53% | -10.11% |
| 5 Years | %th86.00 | 17.94% | -20.45% |
FAQs
Does Dr. Reddy’s (RDY) outperform the market?
Yes,
over the last 12 months RDY made 2.61%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.57%.
Over the last 3 months RDY made 22.01%, while XLV made 0.64%.
Performance Comparison RDY vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RDY vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.6% | -3% | -7.9% | -12% |
| US NASDAQ 100 | QQQ | -1.4% | -3.1% | -8.5% | -10% |
| German DAX 40 | DAX | 0.5% | 3.7% | -20% | -26% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.5% | -1% | -11.3% | -17% |
| Hongkong Hang Seng | HSI | -1.2% | -3.8% | -27.3% | -36% |
| India NIFTY 50 | INDA | 0.2% | -1.2% | -8.2% | 3% |
| Brasil Bovespa | EWZ | -4.1% | -6.6% | -32.9% | -7% |
RDY vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.3% | -3.7% | -12% | -22% |
| Consumer Discretionary | XLY | -1.1% | -0.9% | -0.2% | -15% |
| Consumer Staples | XLP | -2% | 1.6% | -9.5% | -6% |
| Energy | XLE | -2% | -4.8% | -3.8% | 3% |
| Financial | XLF | -2.3% | -2.8% | -12.8% | -27% |
| Health Care | XLV | -1.1% | 0.1% | -0.5% | 7% |
| Industrial | XLI | -1.7% | -2% | -15.7% | -22% |
| Materials | XLB | -3.9% | -2% | -12.4% | -3% |
| Real Estate | XLRE | -1.6% | 1.3% | -7.6% | -10% |
| Technology | XLK | -2.4% | -6.5% | -10.2% | -8% |
| Utilities | XLU | -0.6% | 0.5% | -11.1% | -20% |
| Aerospace & Defense | XAR | 0.5% | -4.8% | -26.4% | -47% |
| Biotech | XBI | -2.6% | -1.1% | 5.4% | 10% |
| Homebuilder | XHB | -4.1% | -4.8% | -0.7% | -3% |
| Retail | XRT | -4.2% | -2.8% | -3.6% | -9% |
RDY vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -2.5% | -6.20% | 0.53% | 10% |
| Natural Gas | UNG | 7.9% | 12.1% | 8.9% | 5% |
| Gold | GLD | -1.9% | 3.5% | -28.5% | -36% |
| Silver | SLV | -2.7% | -4.7% | -25.2% | -15% |
| Copper | CPER | -0.7% | -2.4% | -24.9% | -8% |
RDY vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.2% | 1.2% | -4.4% | 5% |
| iShares High Yield Corp. Bond | HYG | -0.4% | 0.6% | -6.8% | -7% |